Glaxosmithkline reported $89.04B in Assets for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Amgen AMGN:US $ 59294M 98M
AstraZeneca AZN:LN 96579M 3694M
Aurora Cannabis Inc ACB:CN 1.57B 915.13M
Bristol Myers Squibb BMY:US $ 100357M 2677M
Canopy Growth Corp WEED:CN C$ 3.52B 2.1B
Catalent CTLT:US $ 10322M 119M
Corcept Therapeutics CORT:US $ 496.36M 28.24M
Eli Lilly And LLY:US $ 47063.6M 144.3M
Endo International Ordinary Shares ENDP:US $ 6362.26M 2084.95M
GlaxoSmithKline GSK:LN 89045M 644M
Glaxosmithkline GSK:US $ 89045M 644M
Horizon Pharma HZNP:US $ 8853.47M 113.14M
JAZZ PHA JAZZ:US $ 11200.13M 568.78M
Lannett LCI:US $ 572.31M 22.63M
Novartis NOVN:VX SF 122910M 2308M
Pacira Pharmaceuticals PCRX:US $ 1733.99M 157.49M
Perrigo Ordinary Shares PRGO:US $ 10919.6M 530.1M
Phibro Animal Health PAHC:US $ 916.18M 67.22M
Prestige Brands PBH:US $ 3682.23M 11.55M
Supernus Pharmaceuticals SUPN:US $ 1694.97M 55.46M
Takeda 4502:JP Y 14065426M 887408M
Teva Pharmaceutical TEVA:IT 45.93B 1.13B
Valeant Pharmaceuticals VRX:CN $ 36261.71M 7171.71M
Zoetis ZTS:US $ 13770M 90M